Meletios Therapeutics
Lyon
About Meletios Therapeutics
Meletios Therapeutics is an operator of a biotechnology company intended to fulfill the medical need for antiviral molecules against current and emerging diseases. The company offers antiviral drugs by targeting host mechanisms that are hijacked by viruses, enabling healthcare institutions to treat a range of pathologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $5.1M
- Funding stage: Private Equity
- Last round: Grant (Nov 2022)
- Website: meletiostx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/meletios-therapeutics-85063 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.